Sharing risk in Part D Rachel Schmidt and Shinobu Suzuki October 9, - - PowerPoint PPT Presentation

sharing risk in part d
SMART_READER_LITE
LIVE PREVIEW

Sharing risk in Part D Rachel Schmidt and Shinobu Suzuki October 9, - - PowerPoint PPT Presentation

Sharing risk in Part D Rachel Schmidt and Shinobu Suzuki October 9, 2014 Roadmap Quick review of Part Ds approach Mechanisms for sharing risk Experience with risk sharing Issues related to low-income subsidy Potential


slide-1
SLIDE 1

Sharing risk in Part D

Rachel Schmidt and Shinobu Suzuki October 9, 2014

slide-2
SLIDE 2

Roadmap

  • Quick review of Part D’s approach
  • Mechanisms for sharing risk
  • Experience with risk sharing
  • Issues related to low-income subsidy
  • Potential approaches to changes in risk

sharing

2

slide-3
SLIDE 3

Part D’s approach

  • Private plans deliver drug benefits
  • Compete for enrollees
  • Drug-only plans or part of Medicare Advantage
  • Medicare pays for nearly 75% of basic

benefits, enrollees pay 25%

  • Monthly capitated payments to plans
  • Plan premiums vary depending on their bids
  • Medicare has other subsidies that offset risk

3

slide-4
SLIDE 4

Part D’s low-income subsidy (LIS)

  • Beneficiaries at or below 150% of poverty
  • Extra help with premiums
  • Regional threshold—maximum amount

Medicare will pay for an LIS premium

  • CMS randomly assigns LIS enrollees to basic

plans with premiums at/below threshold

  • Extra help with cost sharing
  • Nominal copay amounts set in law
  • No coverage gap

4

slide-5
SLIDE 5

Medicare shares risk with private plans

  • Mechanisms for sharing risk
  • Capitated payments
  • Risk adjustment
  • Individual reinsurance
  • Risk corridors
  • Objectives for sharing risk may have changed
  • Less concern about plan entry and rivalry
  • More concern about managing benefits of high-

cost enrollees

5

slide-6
SLIDE 6

Individual reinsurance: Medicare pays for 80% of benefits above the OOP threshold

6

Initial coverage limit Out-of-pocket threshold Medicare 80% Partial coverage, discounted price for brand-name drugs Deductible Plan 75% Enrollee 25% Plan 15% Enrollee 100% Enrollee 5%

Note: OOP (out of pocket).

slide-7
SLIDE 7

Source: MedPAC based on Table IV.B.10 of the Medicare Board of Trustees’ report for 2014.

Reinsurance has grown 143% since 2007

7

In billions of dollars

42% 36% 35% 32% 19% 24% 26% 31% 39% 40% 38% 37%

$0 $10 $20 $30 $40 $50 $60 $70 2007 2008 2009 2010 2011 2012 2013 Actual incurred program spending

Low-income subsidy Reinsurance Direct subsidy Total 39% 143% 12% Cumulative growth 2007-2013 47%

slide-8
SLIDE 8

Plan at full risk

100% of bid

20% plan, 80% Medicare 20% plan, 80% Medicare 50/50 50/50

Current structure of risk corridors: actual costs relative to bids

95%

  • f bid

105%

  • f bid

110%

  • f bid

90%

  • f bid

Plan gains Plan losses

slide-9
SLIDE 9

Objectives of and experience with risk corridors

  • Initial objective was to establish market for

stand-alone drug plans

  • Risk of attracting high-cost enrollees
  • Little early information on which to base bids
  • Sponsors have consistently bid too high
  • Have paid back Medicare each year
  • Portion of enrollee premiums not paid back

9

slide-10
SLIDE 10

LIS enrollees not distributed equally

  • About one third of Part D enrollees get LIS
  • 75% in PDPs
  • 25% in MA-PDs
  • Among top 20 PDP plans in 2012:
  • 8 had 25% or fewer enrollees with LIS
  • 9 had 75% or more enrollees with LIS
  • Changes to risk sharing could affect

incentives to enroll individuals with LIS

10

slide-11
SLIDE 11

Managing Part D benefits for LIS enrollees is a major concern

  • Higher average

disease burden

  • Higher average

prescription use

  • Lower use of generics
  • More likely to reach

OOP threshold

  • On the order of two-

thirds of Part D program spending for LIS enrollees

Data for 2012 LIS Non- LIS Average risk score 1.195 0.894 Average number of prescriptions per month 5.2 3.8 Average generic dispensing rate 78% 83% Percent with spending high enough to reach OOP threshold 17% 4%

11

Source: MedPAC based on 2012 Part D prescription drug event data. Note: OOP (out of pocket).

Analysis is preliminary and subject to change.

slide-12
SLIDE 12

Market segmentation through minimally enhanced plans

  • LIS enrollees who do not choose a plan can
  • nly be assigned to plans with basic benefits
  • Enhanced plans have higher actuarial value

than basic plans

  • Actuarial value of minimally enhanced not much

higher than basic benefit

  • Often have lower premium than basic plan offered

by same sponsor

  • LIS enrollees cannot be assigned to

enhanced plans

12

slide-13
SLIDE 13

Potential policy approaches

  • Risk sharing
  • Widen or remove corridors
  • Plans pay more than 15% above OOP threshold
  • LIS policies
  • 2012 recommendation on LIS cost sharing
  • Consider premiums and average low-income cost

sharing when setting regional thresholds

  • Reassign LIS enrollees to basic and enhanced

plans if premium at/below regional threshold

  • May need to combine policy approaches to

balance competing goals

13